Ad is loading...
SEIRX
Price
$17.54
Change
+$0.12 (+0.69%)
Updated
Nov 22 closing price
VGSNX
Price
$21.12
Change
+$0.18 (+0.86%)
Updated
Nov 22 closing price
Ad is loading...

SEIRX vs VGSNX

Header iconSEIRX vs VGSNX Comparison
Open Charts SEIRX vs VGSNXBanner chart's image
SEI Real Estate I (SIMT)
Price$17.54
Change+$0.12 (+0.69%)
VolumeN/A
CapitalizationN/A
Vanguard Real Estate Index Institutional
Price$21.12
Change+$0.18 (+0.86%)
VolumeN/A
CapitalizationN/A
SEIRX vs VGSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SEIRX vs. VGSNX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SEIRX is a StrongBuy and VGSNX is a Buy.

FUNDAMENTALS
Fundamentals
VGSNX has more cash in the bank: 68.9B vs. SEIRX (76.7M). VGSNX pays higher dividends than SEIRX: VGSNX (4.01) vs SEIRX (1.42). SEIRX was incepted earlier than VGSNX: SEIRX (17 years) vs VGSNX (21 years). SEIRX is a more actively managed with annual turnover of: 53.00 vs. VGSNX (9.00). SEIRX has a lower initial minimum investment than VGSNX: SEIRX (100000) vs VGSNX (5000000). SEIRX annual gain was more profitable for investors over the last year : 30.71 vs. VGSNX (26.24). VGSNX return over 5 years is better than : 27.07 vs. SEIRX (12.21).
SEIRXVGSNXSEIRX / VGSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years21 years-
Gain YTD16.67612.285136%
Front LoadN/AN/A-
Min. Initial Investment10000050000002%
Min. Initial Investment IRAN/AN/A-
Net Assets76.7M68.9B0%
Annual Yield % from dividends1.424.0135%
Returns for 1 year30.7126.24117%
Returns for 3 years-4.15-1.19348%
Returns for 5 years12.2127.0745%
Returns for 10 years6.1370.089%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLSI13.550.58
+4.47%
Greenwich LifeSciences
SNA365.974.57
+1.26%
Snap-on
EWTX32.200.22
+0.69%
Edgewise Therapeutics
RDWR23.17-0.01
-0.04%
Radware Ltd
IMRN1.88-0.03
-1.53%
Immuron Limited